Growth Metrics

Ginkgo Bioworks Holdings (DNA) Income from Continuing Operations: 2020-2025

Historic Income from Continuing Operations for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -$80.8 million.

  • Ginkgo Bioworks Holdings' Income from Continuing Operations fell 43.18% to -$80.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$339.5 million, marking a year-over-year increase of 47.86%. This contributed to the annual value of -$547.0 million for FY2024, which is 38.73% up from last year.
  • Ginkgo Bioworks Holdings' Income from Continuing Operations amounted to -$80.8 million in Q3 2025, which was down 33.92% from -$60.3 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' 5-year Income from Continuing Operations high stood at -$54.5 million for Q2 2021, and its period low was -$1.6 billion during Q4 2021.
  • For the 3-year period, Ginkgo Bioworks Holdings' Income from Continuing Operations averaged around -$152.0 million, with its median value being -$165.9 million (2024).
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Income from Continuing Operations plummeted by 3,359.12% in 2021, and later soared by 89.22% in 2022.
  • Ginkgo Bioworks Holdings' Income from Continuing Operations (Quarterly) stood at -$1.6 billion in 2021, then soared by 89.22% to -$173.1 million in 2022, then fell by 22.31% to -$211.7 million in 2023, then skyrocketed by 49.20% to -$107.5 million in 2024, then crashed by 43.18% to -$80.8 million in 2025.
  • Its Income from Continuing Operations was -$80.8 million in Q3 2025, compared to -$60.3 million in Q2 2025 and -$91.0 million in Q1 2025.